233 related articles for article (PubMed ID: 35267084)
41. Pleomorphic adenoma: the great mimicker of malignancy.
Hernandez-Prera JC; Skálová A; Franchi A; Rinaldo A; Vander Poorten V; Zbären P; Ferlito A; Wenig BM
Histopathology; 2021 Sep; 79(3):279-290. PubMed ID: 33368685
[TBL] [Abstract][Full Text] [Related]
42. Low p53 protein expression in salivary gland tumours compared with lung carcinomas.
Soini Y; Kamel D; Nuorva K; Lane DP; Vähäkangas K; Pääkkö P
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):415-20. PubMed ID: 1333678
[TBL] [Abstract][Full Text] [Related]
43. Salivary gland tumors studied by means of the AgNOR technique.
Epivatianos A; Trigonidis G
Ann Dent; 1994; 53(2):21-5. PubMed ID: 7847771
[TBL] [Abstract][Full Text] [Related]
44. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Andreasen S; von Holstein SL; Homøe P; Heegaard S
Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
[TBL] [Abstract][Full Text] [Related]
45. A microRNA signature for the differential diagnosis of salivary gland tumors.
Denaro M; Navari E; Ugolini C; Seccia V; Donati V; Casani AP; Basolo F
PLoS One; 2019; 14(1):e0210968. PubMed ID: 30682201
[TBL] [Abstract][Full Text] [Related]
46. An update on molecular diagnostics of squamous and salivary gland tumors of the head and neck.
Hunt JL
Arch Pathol Lab Med; 2011 May; 135(5):602-9. PubMed ID: 21526958
[TBL] [Abstract][Full Text] [Related]
47. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.
Foo WC; Jo VY; Krane JF
Cancer Cytopathol; 2016 Jun; 124(6):397-405. PubMed ID: 26882287
[TBL] [Abstract][Full Text] [Related]
48. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation.
Hsieh MS; Wang H; Lee YH; Ko JY; Chang YL
Hum Pathol; 2017 Mar; 61():9-18. PubMed ID: 27769871
[TBL] [Abstract][Full Text] [Related]
49. CRTC1-MAML2 and CRTC3-MAML2 fusions were not detected in metaplastic Warthin tumor and metaplastic pleomorphic adenoma of salivary glands.
Skálová A; Vanecek T; Simpson RH; Vazmitsel MA; Majewska H; Mukensnabl P; Hauer L; Andrle P; Hosticka L; Grossmann P; Michal M
Am J Surg Pathol; 2013 Nov; 37(11):1743-50. PubMed ID: 24121173
[TBL] [Abstract][Full Text] [Related]
50. Advances in salivary gland pathology.
Cheuk W; Chan JK
Histopathology; 2007 Jul; 51(1):1-20. PubMed ID: 17539914
[TBL] [Abstract][Full Text] [Related]
51. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.
Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC
Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156
[TBL] [Abstract][Full Text] [Related]
52. "Pancreatic Mucoepidermoid Carcinoma" Is not a Pancreatic Counterpart of CRTC1/3-MAML2 Fusion Gene-related Mucoepidermoid Carcinoma of the Salivary Gland, and May More Appropriately be Termed Pancreatic Adenosquamous Carcinoma With Mucoepidermoid Carcinoma-like Features.
Saeki K; Ohishi Y; Matsuda R; Mochidome N; Miyasaka Y; Yamamoto H; Koga Y; Maehara Y; Nakamura M; Oda Y
Am J Surg Pathol; 2018 Nov; 42(11):1419-1428. PubMed ID: 30138216
[TBL] [Abstract][Full Text] [Related]
53. Utility of MUC4 in the diagnosis of secretory carcinoma of salivary glands.
Fatima S; Ahmed A; Suleman S; Din NU
Ann Diagn Pathol; 2023 Dec; 67():152220. PubMed ID: 37924657
[TBL] [Abstract][Full Text] [Related]
54. Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases.
El Hallani S; Udager AM; Bell D; Fonseca I; Thompson LDR; Assaad A; Agaimy A; Luvison AM; Miller C; Seethala RR; Chiosea S
Am J Surg Pathol; 2018 Jan; 42(1):18-27. PubMed ID: 29135520
[TBL] [Abstract][Full Text] [Related]
55. Heterogeneity of Genetic Landscapes in Salivary Gland Tumors and Their Critical Roles in Current Management.
Yousaf A; Sulong S; Abdullah B; Lazim NM
Medeni Med J; 2022 Jun; 37(2):194-202. PubMed ID: 35735183
[TBL] [Abstract][Full Text] [Related]
56. Fine needle aspiration biopsy of salivary gland tumours. Problems and pitfalls.
Orell SR; Nettle WJ
Pathology; 1988 Oct; 20(4):332-7. PubMed ID: 2853862
[TBL] [Abstract][Full Text] [Related]
57. Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.
Morita M; Murase T; Okumura Y; Ueda K; Sakamoto Y; Masaki A; Kawakita D; Tada Y; Nibu KI; Shibuya Y; Inagaki H
Histopathology; 2020 Jun; 76(7):1013-1022. PubMed ID: 32129900
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic utility of fluorescence in situ hybridization testing on cytology cell blocks for the definitive classification of salivary gland neoplasms.
Darras N; Mooney KL; Long SR
J Am Soc Cytopathol; 2019; 8(3):157-164. PubMed ID: 31097292
[TBL] [Abstract][Full Text] [Related]
59. Clinical implication of CD166 expression in salivary gland tumor.
Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
[TBL] [Abstract][Full Text] [Related]
60. Histologic grading and prognostic biomarkers in salivary gland carcinomas.
Seethala RR
Adv Anat Pathol; 2011 Jan; 18(1):29-45. PubMed ID: 21169736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
